Literature DB >> 17044031

Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury.

Ken Ishii1, Masaya Nakamura, Haining Dai, Tom P Finn, Hideyuki Okano, Yoshiaki Toyama, Barbara S Bregman.   

Abstract

Transplantation of neural stem cells (NSC) into lesioned spinal cord offers the potential to increase regeneration by replacing lost neurons or oligodendrocytes. The majority of transplanted NSC, however, typically differentiate into astrocytes that may exacerbate glial scar formation. Here we show that blocking of ciliary neurotrophic factor (CNTF) with anti-CNTF antibodies after NSC transplant into spinal cord injury (SCI) resulted in a reduction of glial scar formation by 8 weeks. Treated animals had a wider distribution of transplanted NSC compared with the control animals. The NSC around the lesion coexpressed either nestin or markers for neurons, oligodendrocytes, or astrocytes. Approximately 20% fewer glial fibrillary acidic protein-positive/bromodeoxyuridine (BrdU)-positive cells were seen at 2, 4, and 8 weeks postgrafting, compared with the control animals. Furthermore, more CNPase(+)/BrdU(+) cells were detected in the treated group at 4 and 8 weeks. These CNPase(+) or Rip(+) mature oligodendrocytes were seen in close proximity to host corticospinal tract (CST) and 5HT(+) serotonergic axon. We also demonstrate that the number of regenerated CST fibers both at the lesion and at caudal sites in treated animals was significantly greater than that in the control animals at 8 weeks. We suggest that the blocking of CNTF at the beginning of SCI provides a more favorable environment for the differentiation of transplanted NSC and the regeneration of host axons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044031     DOI: 10.1002/jnr.21079

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  25 in total

Review 1.  Approaches to neural tissue engineering using scaffolds for drug delivery.

Authors:  Stephanie M Willerth; Shelly E Sakiyama-Elbert
Journal:  Adv Drug Deliv Rev       Date:  2007-04-10       Impact factor: 15.470

2.  Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injury.

Authors:  Robin E White; Meghan Rao; John C Gensel; Dana M McTigue; Brian K Kaspar; Lyn B Jakeman
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

Review 3.  Don't fence me in: harnessing the beneficial roles of astrocytes for spinal cord repair.

Authors:  Robin E White; Lyn B Jakeman
Journal:  Restor Neurol Neurosci       Date:  2008       Impact factor: 2.406

4.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

Review 5.  Current challenges for the advancement of neural stem cell biology and transplantation research.

Authors:  Kristien Reekmans; Jelle Praet; Jasmijn Daans; Veerle Reumers; Patrick Pauwels; Annemie Van der Linden; Zwi N Berneman; Peter Ponsaerts
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

6.  NT3-chitosan enables de novo regeneration and functional recovery in monkeys after spinal cord injury.

Authors:  Jia-Sheng Rao; Can Zhao; Aifeng Zhang; Hongmei Duan; Peng Hao; Rui-Han Wei; Junkui Shang; Wen Zhao; Zuxiang Liu; Juehua Yu; Kevin S Fan; Zhaolong Tian; Qihua He; Wei Song; Zhaoyang Yang; Yi Eve Sun; Xiaoguang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

7.  Phenotypic analysis of astrocytes derived from glial restricted precursors and their impact on axon regeneration.

Authors:  Christopher Haas; Birgit Neuhuber; Takaya Yamagami; Mahendra Rao; Itzhak Fischer
Journal:  Exp Neurol       Date:  2011-11-10       Impact factor: 5.330

8.  Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury.

Authors:  Jeannette E Davies; Christoph Pröschel; Ningzhe Zhang; Mark Noble; Margot Mayer-Pröschel; Stephen J A Davies
Journal:  J Biol       Date:  2008-09-19

Review 9.  Cell therapy for spinal cord regeneration.

Authors:  Stephanie M Willerth; Shelly E Sakiyama-Elbert
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

Review 10.  Bridging spinal cord injuries.

Authors:  James W Fawcett
Journal:  J Biol       Date:  2008-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.